Business

Biocom Announces Powerhouse Keynote Panel Featuring Heads of Discovery and Research & Development from AbbVie, Amgen and Eli Lilly at 2026 Global Partnering & Investor Conference

SAN DIEGO, January 21, 2026--Biocom today announced a distinguished keynote session for its 2026 Global Partnering & Investor Conference, taking place February 24 to 26 at The Lodge at Torrey Pines in La Jolla, California.

articleAmgen Inc.January 21, 20263/company/amgen-inc/news/biocom-announces-powerhouse-keynote-panel-featuring-heads-of-discovery-and-research-and-development-from-abbvie-amgen-and-eli-lilly-at-2026-global-partnering-and-investor-conference-1
Biocom Announces Powerhouse Keynote Panel Featuring Heads of Discovery and Research & Development from AbbVie, Amgen and Eli Lilly at 2026 Global Partnering & Investor Conference

About this update from Amgen Inc.

[{"type":"image","alt":"Biocom’s Global Partnering & Investor Conference brings together over 500 investors and senior executives, including CEOs and heads of business development, biotech, and research and development from leading pharmaceutical, biotech and research organizations from over 20 countries. This prestigious conference features panel discussions, one-on-one partnering meetings, presentations from small companies and leading research institutions, and endless networking opportunities. Learn more and register: https://www.biocomglobalpartnering.org.","displaySize":"","headline":null,"caption":"Biocom’s Global Partnering & Investor Conference brings together over 500 investors and senior executives, including CEOs and heads of business development, biotech, and research and development from leading pharmaceutical, biotech and research organizations from over 20 countries. This prestigious conference features panel discussions, one-on-one partnering meetings, presentations from small companies and leading research institutions, and endless networking opportunities. Learn more and register: https://www.biocomglobalpartnering.org.","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1000,"height":328,"url":"https://media.zenfs.com/en/business-wire.com/cd0edc9343dd2e6691c3cef19f8e87ed"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/46Hd_f_bxf4sYdFJbsee5g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMxNTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/cd0edc9343dd2e6691c3cef19f8e87ed","width":960,"height":315},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/4HIz6fyfYlb_P_TJpQuHgg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwMDA7aD02NTY7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/cd0edc9343dd2e6691c3cef19f8e87ed","width":1000,"height":328}},"lazy":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":4685,"height":1453,"url":"https://media.zenfs.com/en/business-wire.com/a6e4dee76cd7f9742b55aea565f7ca32"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/rdZvp7_DSUVITLE7_IYZcw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTI5ODtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/a6e4dee76cd7f9742b55aea565f7ca32","width":960,"height":298},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/O3IP2uK...

More updates from Amgen Inc.

Biocomresearch and developmentLilly Research LaboratoriesInvestor Conferenceresearch institutionspanel discussionsnetworking opportunitiesGlobal Partnering & Investor Conferencebusiness developmentpharmaceutical